1181 A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2A (40KD) (PEGSYS®) alone or in combination with lamivudine vs lamivudine in 546 patients with HBEAG-negative/anti-HBE-positive chronic hepatitis B

✍ Scribed by MARCELLIN, P; LAU, G; BONINO, F; FARCI, P; HADZIYANNIS, S; JIN, R; LU, Z; PIRATVISUTH, T; GERMANIDIS, G; YURDAYDIN, C

• Book ID: 122091739
• Publisher: John Wiley and Sons
• Year: 2003
• Tongue: English
• Weight: 214 KB
• Volume: 38
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1016/S0270-9139(03)81219-3